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ABSTRACT
Introduction Postnatal depression (PND) affects 
approximately 13% of new mothers. Community- based 
activities are sought after by many mothers, especially mothers 
that prefer not to access pharmacological or psychological 
interventions. Singing has shown positive effects in maternal 
mood and mother–child bonding. The Scaling- Up Health- Arts 
Programmes: Implementation and Effectiveness Research- 
Postnatal Depression study will analyse the clinical and 
implementation effectiveness of 10- week singing sessions 
for PND in new mothers. This protocol paper will focus on the 
clinical effectiveness of this trial.
Methods and analysis A total of 400 mothers with PND (with 
a score of at least 10 on the Edinburgh Postnatal Depression 
Scale) and their babies will be recruited for this hybrid type II 
randomised controlled trial. The intervention group will attend 
10 weekly singing sessions held at community venues or 
online, facilitated by the arts organisation, Breathe Arts Health 
Research (Breathe). A control group will be encouraged to 
attend non- singing sessions in the community or online for 
10 weeks. A package of assessments will be collected from 
participants for clinical, mechanistic and implementation 
outcomes, at different stages of the trial. Clinical assessments 
will include questionnaires and interviews for demographics, 
mental health and social measures, together with biological 
samples for measurement of stress markers; the study visits 
are at baseline, week 6 (mid- trial) and week 10 (end of trial), 
with follow ups at weeks 20 and 36. Multiple imputation will 
be used to deal with possible missing data and multivariable 
models will be fitted to assess differences between groups in 
the outcomes of the study.
Ethics and dissemination Ethical approval has been 
granted by the London- West London and GTAC Research 
Ethics Committee, REC reference: 20/PR/0813.
Trial registration number NCT04834622; Pre-results.
INTRODUCTION
Postnatal depression
Postnatal depression (PND) affects approxi-
mately 13% of new mothers, with symptoms 
including low mood, fatigue, anhedonia, 
insomnia and irritability.1 2 Although phar-
macological treatment has yielded positive 
results, these are hampered by low uptake 
and adherence, and while psychotherapy has 
produced mixed results, poses similar chal-
lenges, including short- lived improvements.2–5
Prior studies have found that PND carries 
implications for not only maternal health 
and well- being, but also for the mother–
infant relationship.6 A common finding is 
that, while interacting with their babies, 
depressed mothers spend more time in nega-
tive, withdrawn states7 8 and exhibit reduced 
sensitivity,9 10 and in turn, their infants 
mirror this behaviour by disengaging and 
adopting a passive behavioural style.7 More-
over, depressed mothers are more likely to 
report reduced feelings of attachment toward 
their infant11 and are less likely to mentalise 
appropriately with their newborn.12 Maternal 
sensitivity is highly predictive of infant secure 
attachment,13 which has long been linked to 
optimal developmental outcomes including 
mental health;14 thus, intervention early- on 
to ameliorate the mother–infant interaction 
is warranted in order to protect offspring 
future development. However, while home- 
based interventions have been successful in 
Strengths and limitations of this study
 ► Largest cohort of participants in a study examining 
singing in postnatal depression.
 ► Largest cohort studying biological measures in rela-
tion to an arts intervention for postnatal depression.
 ► Largest study to analyse the effect of an arts inter-
vention on the mother–infant interaction.
 ► The state- of- the- art design will result in a unique 
package of clinical and implementation effective-
ness on this intervention.
 ► There may be inconsistency throughout an interven-
tion period if in- person sessions are switched online 
due to COVID- 19 social distancing restrictions.
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improving PND, they show limited efficacy in helping the 
relationship itself.15 Indeed, a recent combined psychoed-
ucation and play intervention in a community setting was 
found to decrease dysfunctional parenting behaviours, 
but the intervention proved more effective in PND 
symptom reduction than in interaction improvement;16 
and a very small case study found that mother–infant 
painting sessions were successful in improving both the 
relationship and PND symptoms, though the sample size 
was only four dyads.17
Despite these challenges in finding optimal treatment 
options, which can both alleviate maternal symptoms of 
PND and strengthen the mother–infant relationship, 
many mothers continue to engage in community group 
activities, such as mother–infant play groups, as they are 
found to be effective at relaxing mothers, providing good 
sources of social interaction, decreasing the monotony 
of each day, and providing a sense of personal fulfil-
ment for mothers.18 Specifically, there is a growing body 
of evidence demonstrating the effects of community 
group singing on mental health19 20 (see also the Melo-
dies for Mums (M4M) programme, described below). 
Singing to newborns is practised around the world, and 
research has demonstrated valuable benefits such as 
improving mother–infant interaction and reducing infant 
distress.21–23 Listening to music during pregnancy is also 
associated with greater maternal well- being and reduced 
symptoms of PND in the first 3 months postbirth, and, 
additionally, daily singing to babies is associated with 
fewer symptoms of PND and increased maternal well- 
being, self- esteem and perceived mother–infant bond.24 
Consequently, there is a strong theoretical background 
for why singing could support mothers with PND. It is 
thought that postnatally depressed women may have diffi-
culty with adherence to dyadic interventions given the 
nature and challenge of their symptoms25; however, no 
prior studies have assessed whether a community singing- 
based intervention may be able to both improve the 
quality of the developing relationship, as well as present 
as a more engaging intervention that mothers are likelier 
to complete.
Biological underpinning of singing sessions for PND
Three biological pathways are suggested to underlie 
the benefits of music engagement on mood: the 
glucocorticoid- modulated stress system, the inflam-
matory system and the oxytocin system, which is also 
associated with maternal attachment and bonding. Of 
these, the hypothalamic–pituitary–adrenal axis, of which 
the hormone cortisol is a main measure, is the most 
well studied. Studies in various populations have given 
evidence for a reduction in salivary cortisol after a singing 
session,26–29 pointing to a consistent stress- reducing 
effect of singing. Interestingly, one of these studies also 
showed that singing sessions produced increases in the 
levels of cytokines such as IL- (interleukin- )17, IL- 2, IL- 4 
and tumour necrosis factor (TNF)-α, which correlated 
with the observed reduction in cortisol.27 The evidence 
surrounding the oxytocin system and music participa-
tion is more conflicted. Oxytocin is generally shown to 
increase as a result of singing,30 31 or even listening to 
music.32 However, more recent studies have demonstrated 
a decrease in salivary oxytocin concentrations in certain 
circumstances, for example, after choir singing, but not 
solo singing.28 In addition, one study showed a decrease 
in oxytocin after singing sessions, which was associated 
with the increase in cytokines and reduction in cortisol, 
as described above.27 This was proposed to be indicative 
of a general dampening of all stress- related signalling, 
in which oxytocin also plays a part, leading to an overall 
improved sense of well- being.
Studies investigating the interplay of these three biolog-
ical systems in relation to musical engagement during the 
perinatal period are sparse. Indeed, only one study has 
investigated the biological effects of maternal singing 
groups,33 in which pregnant women were randomised 
to either music intervention, singing intervention or 
control group. This study found a decrease in cortisol in 
both intervention groups, but that the effect was stronger 
in the singing group. Additionally, both musical inter-
vention groups showed an increase in salivary oxytocin 
post- session. This is of particular interest given oxyto-
cin’s involvement in the mother–infant relationship,34 
which may be strengthened in cases of mother–child 
biobehavioural synchrony, in which maternal and infant 
hormone levels covary.35
The ‘M4M’ intervention
M4M is an intervention that was developed and tested 
as part of a collaboration between the Royal College 
of Music, Imperial College London and University 
College London (UK). M4M was tested in a three- arm 
randomised controlled trial (RCT) involving 134 mothers 
with PND (with an Edinburgh Postnatal Depression Scale 
(EPDS) score ≥10 at baseline, indicating depression), 
and compared the efficacy of community singing with 
a comparison group (10 weeks of creative play classes 
for dyads) and a wait- list control group (10 weeks of 
care- as- usual). This pilot study found that mothers with 
moderate- to- severe symptoms of PND, defined as an 
EPDS score of ≥13, who participated in the programme 
with their baby, had a significantly faster improvement in 
symptoms than mothers in usual care.36
Following the pilot study, M4M was taken- on as a service 
by Breathe Arts Health Research (Breathe) across the 
boroughs of Lambeth and Southwark, in South London. 
However, there has since been no further research on 
the programme; thus, its effectiveness on a larger scale 
remains to be evaluated, as do the acceptability, appropri-
ateness and feasibility of its delivery on a larger scale, and 
its potential to be adopted and sustained as a cost- effective, 
beneficial service for mothers within national health 
services. In addition, there is no evidence on the effects 
of M4M on mother–infant interaction, and a detailed 
mechanistic investigation of the biological underpinning 
of any therapeutic effects is also missing. This paper will 
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focus specifically on the protocol for a Wellcome- Trust- 
funded study aimed to deliver the clinical effectiveness 
and the biomarkers evaluation of M4M, the ‘Scaling- Up 
Health- Arts Programmes: Implementation and Effective-
ness Research- Postnatal Depression’ (SHAPER- PND) 
study. Information on the implementation effectiveness 
of M4M is discussed in a separate detailed protocol.
METHODS AND ANALYSIS
Aims
1. To determine the clinical effectiveness of the inter-
vention in a larger sample size than previous studies 
(n=400 women and their babies). This will allow us to 
ascertain whether the initial findings from the pilot 
study are replicable on a larger scale. To understand 
whether singing is an efficacious treatment for PND, 
including on mother–infant interaction, various psy-
chological, social and qualitative measures will be col-
lected from women and their infants before, during 
and after the intervention period.
2. To ascertain the biological mechanisms by which 
postnatal singing groups putatively improve maternal 
mood and mother–infant relationships. This will fur-
ther the current understanding of the positive effects 
of the intervention and provide objectively measurable 
outcomes. Maternal and infant samples will be collect-
ed to measure cortisol and oxytocin, plus maternal in-
flammatory markers.
Objectives and outcomes
To address our aims, we have the following objectives 
and outcomes. As this protocol paper is focusing only on 
the clinical effectiveness of the trial, the objectives and 
outcomes of the implementation component of the trial 
have been reported in a separate manuscript.37
Primary objective
1. Does community singing improve symptoms of PND?
Participants will complete the EPDS prior to the inter-
vention (baseline) to ascertain the severity of their PND. 
The EPDS will be administered again at various time 
points throughout and following the intervention period 
(weeks 6, 10, 20 and 36).
Outcome: The primary outcome of this study is to 
understand whether singing reduces the severity of symp-
toms of PND on the EPDS between baseline and week 10 
(end of intervention), via a reduction in total EPDS score.
Secondary objectives
1. To assess whether singing improves (changes) further 
aspects of mental health, including depression us-
ing the Hamilton Depression Rating Scale (HDRS). 
Time frame: Compare change between baseline and 
weeks 6, 10, 20 and 36.
2. To assess whether singing improves (changes) further 
aspects of mental health, including depression using 
the Beck Depression Inventory (BDI). Time frame: 
Compare change between baseline and weeks 6, 10, 
20 and 36.
3. To assess whether singing improves (changes) further 
aspects of mental health, including stress using the 
Perceived Stress Scale (PSS). Time frame: Compare 
change between baseline and weeks 6, 10, 20 and 36.
4. To assess whether singing improves (changes) further 
aspects of mental health, including well- being using 
the Office for National Statistics Well- being Scale. 
Time Frame: Compare change between baseline and 
weeks 6, 10, 20 and 36.
5. To assess whether singing improves (changes) further 
aspects of mental health, including anxiety, using 
the State- Trait Anxiety Scale. Time frame: Compare 
change between baseline and weeks 6, 10, 20 and 36.
6. To ascertain whether singing improves the observed 
mother–infant interaction using the Crittenden 
CARE- Index. Time frame: Compare change between 
baseline and weeks 10 and 36.
7. To ascertain whether singing improves the perceived 
mother–infant relationship using the Maternal 
Postpartum Attachment Scale. Time frame: Compare 
change between baseline and weeks 6, 10, 20 and 36.
8. To ascertain whether singing improves the per-
ceived mother–infant relationship using the Parent 
Reflective Functioning Questionnaire. Time frame: 
Compare change between baseline and weeks 6, 10, 
20 and 36.
9. To ascertain whether singing improves social sup-
port and reduces loneliness using the University of 
California Los Angeles (UCLA) Loneliness Scale. 
Time frame: Compare change between baseline and 
weeks 6, 10, 20 and 36.
10. To ascertain whether singing improves social support 
and reduces loneliness using the Multidimensional 
Scale of Perceived Social Support Time frame: 
Compare change between baseline and weeks 6, 10, 
20 and 36.
11. To identify whether there are biological mechanisms 
underpinning the psychological outcomes assessed 
using changes in measurements in stress hormones, 
including hair cortisol, diurnal cortisol and salivary 
cytokines. Time frame: Compare change between 
week 1 and weeks 6 and 10.
12. To identify whether there are biological mechanisms 
underpinning the psychological outcomes assessed 
using changes in measurements in salivary oxytocin. 
Time frame: Compare change between week 1 and 
weeks 6 and 10.
13. To identify how the singing sessions affect the lived 
experience of mothers with PND using focus groups. 
Time frame: Qualitative data collection at week 10 
(end of intervention).
14. To explore the phenomenology of PND and how 
singing intersects with PND among women with 
particular risk factors for PND (traumatic birth, ad-
verse childhood experiences and social isolation/
loneliness) using semistructured interviews. Time 
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frame: Qualitative data collection at week 10 (end of 
intervention).
Data collection plan
The study is anticipated to run from September 2021 to 
December 2023.
In order to address the objectives within the clinical 
effectiveness arm of the study, data will be collected 
according to the data collection timeline in table 1.
In addition to the measures collected above, we will 
also collect comprehensive information on maternal and 
infant sociodemographics and medical health, maternal 
history of childhood maltreatment and current maternal 
abuse, in order to explore the interaction between 
notable risk factors and the development of PND.
Trial design
SHAPER is a multidisciplinary research programme 
funded by the Wellcome Trust that is hosted by King’s 
College London (Sponsor) and University College 
London. The SHAPER- PND study described here is 
Hybrid Type II Effectiveness- Implementation RCT, where 
equal focus is placed on the effectiveness of the interven-
tion and the effectiveness of its implementation.38
Study flow chart
An overview of the study timelines and procedures has 
been summarised in the flowchart below (figure 1).
Setting
This is a multicentre trial that will be run in locations 
across London (primarily in the South London boroughs 
of Lewisham, Lambeth and Southwark), specifically in 
children’s or community venues or online. These venues 
will be thoroughly safety and risk assessed in light of 
COVID- 19 and adherence to any COVID- secure measures 
will be closely monitored by Breathe.
In order to enrol a sufficiently large sample of women, 
there will be 12 blocks of the 10- week singing programme 
in total: 10 intervention blocks will be for the experi-
mental group, and 2 blocks will be for women in the wait- 
list control group that wish to take part in the singing 
sessions. The two wait- list blocks will be offered singing 
sessions after a woman has completed the first 10 weeks 
of the study and no data will be collected regarding these 
singing sessions, apart from the control follow- up data 
that this group is expected to provide.
In the event that one or several women need to self- 
isolate due to confirmed or suspected exposure to 
COVID- 19, the sessions will be delivered to her/them 




measure Measures Time point collected Type of data
1 Mental 
health





Hamilton Depression Rating Scale, Structured Clinical 
Interview for DSM- IV Disorders
Weeks 1 and 10 Quantitative
Beck Depression Inventory, State Trait Anxiety Inventory, 
Perceived Stress Scale; Office for National Statistics Well- 
being Scale
Weeks 1, 6, 10, 20 and 36
3 Social Maternal Postpartum Attachment Scale, Parental 
Reflective Functioning Questionnaire
Weeks 1, 6, 10, 20 and 36 Quantitative
Crittenden Child- Adult Relationship)* Baseline, weeks 10 and 36
4 Social University of California Los Angeles (UCLA) 
Loneliness Scale, Short General Self- Efficacy Scale, 
Multidimensional Scale of Perceived Social Support
Weeks 1, 6, 10, 20 and 36 Quantitative
5 Biological Diurnal cortisol saliva samples* Baseline and week 10 Quantitative
Presession and postsession saliva samples* Weeks 1, 6, 10 (at 
sessions)
Hair samples Week 10
6 Qualitative Focus groups with intervention groups to capture 
feedback from sessions and experiences from mothers in 
the groups, focusing on the lived experience of PND
Week 10 Qualitative
7 Qualitative Semi- structured interviews with a sub sample of the 
intervention group of women self- reporting particular 
risk factors for PND (partially informed by demographic 
questionnaires)
Weeks 10–20, informed by 
information collected at 
baseline
Qualitative
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online via Zoom. This will allow for the sessions to still be 
conducted in person with the remaining women.
In the event of the artist or the Breathe officer having 
to self- isolate, a replacement Breathe- trained artist will be 
ready to step- in and deliver the sessions. The same will 
apply to Breathe staff; there will be another staff member 
available to be present at the sessions.
Participants
Study participants will be new mothers exhibiting symp-
toms of PND, who meet criteria for a current major 
depressive episode, and have babies aged 0–9 months.
Inclusion criteria: Women aged 18 or older; satisfactory 
understanding of English; women with infants aged 0–9 
months; women with PND, who score ≥10 on the EPDS. 
Women will require access to an internet- connected 
device (mobile phone, tablet, computer or laptop) to 
allow completion of assessments and participation in the 
singing sessions in the event they go online.
Exclusion criteria: The participant may not enter the 
study if her baby is outside of the age- range specified; if 
she is unable to give informed consent.
Number of participants and power analysis
The pilot RCT that informed this study showed that 
depressive symptoms (EPDS scores) improved in both 
singing and control women by the end of treatment 
(week 10), but the singing group had a numerically 
larger improvement (−5.2 (SD=2.8)) than the care- as- 
usual group (−4.25 (SD=3.2), effect size=0.32)).36 To 
have power of 80% (at p<0.05, two tailed) to detect the 
same effect size difference, randomising subjects 2:1, 232 
subjects will be required in the intervention and 116 in 
the control group (total=348). In total, 400 mothers and 
their babies will be recruited to compensate for a 12% 
drop- out rate.
Participants will be recruited in blocks of 40–50 women 
and their babies, screened and assessed, prior to a 2:1 allo-
cation randomisation (dyads will be allocated the same 
group). This process will be repeated 10 times, aiming to 
reach 400 dyads.
Recruitment process
The recruitment period will last 2 years (2021–2022). 
All potential participants will initially be directed to a 
Figure 1 SHAPER- PND study flow chart. EPDS, Edinburgh Postnatal Depression Scale; PIS, participant information sheet; 
SHAPER- PND, Scaling- Up Health- Arts Programmes: Implementation and Effectiveness Research- Postnatal Depression.
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prescreening online form that includes an EPDS. If the 
EPDS score is <10, a participant will be notified that she 
is not currently eligible to participate and will be sign-
posted to other support services within the community 
(eg, talking therapies, mother–baby groups, baby activity 
group). If a woman’s score is ≥10, she will be notified that 
she is potentially eligible and will proceed straight to the 
second phase of screening through a home (or Zoom) 
visit. The participant information sheet for the trial will 
be sent once the baseline assessment is booked.
When a new round of 10 classes becomes available, 
researchers will arrange assessments with potential 
participants to undertake the full screening interview 
against the inclusion/exclusion criteria. If the partici-
pant is found non- eligible, she will be signposted to other 
support services within the community.
The singing group
M4M is a 10- week intervention for mothers with PND. 
The programme will be delivered to groups of 8–12 
mothers in weekly sessions lasting 1 hour. Mothers will 
start a block of 10- week classes together and continue 
with the same group and leader for the duration of the 
course. Classes are free to attend and will take place in 
Children’s Centres or other community venues (or online 
via Zoom). Mothers will attend with their babies and will 
be invited to sit in a socially distanced circle on the floor 
surrounded by soft play cushions and mats. Classes will 
start with welcome songs, introducing the babies and 
mothers to one another, and then involve a range of 
singing and music activities. Mothers will be required to 
respect social distancing guidelines and keep their babies 
within their reach to avoid physical contact with other 
mothers or their babies.
Some songs will be accompanied by maracas, drums, 
hand chimes and other simple instruments that the 
mothers and babies can play together. Instruments such 
as guitar and ukulele will also be used for a small number 
of songs. Instruments will not be shared between the 
participants and will be disinfected before and after the 
singing sessions with a COVID- 19 validated disinfectant.
Mothers will also work to write some of their own 
songs over the weeks, developing lyrics together about 
their babies or experiences of motherhood and creating 
simple melodies. Recordings of the group singing the 
songs together will be made and uploaded to private 
online platforms or onto CDs for the mothers to listen 
to at home. Classes will be led by professional workshop 
leaders trained by Breathe, with support of assistants.
The control group
The control group will be an ‘active’ control. During 
the first 10 weeks (during the study period), mothers 
in the control group will receive details of other non- 
music classes available to them in the community (either 
in- person or online, depending on the programmes 
available at the time and government guidelines) and 
will receive the same schedule of texts and phone calls 
to encourage them to join these activities. They will still 
be seen by the researchers to collect clinical measures 
and biological samples (including the pre–post saliva 
samples) and to monitor engagement in other activities. 
Following the first 10 weeks, the mothers in the control 
group will be offered a place on the singing programme, 
but these data will not be part of the study, and they will 
not join groups with other women who are in the study.
Patient and public involvement
Participants from previous sessions delivered by Breathe 
in the community have provided valuable feedback and 
insights into the sessions’ delivery, content and schedule. 
These were gathered through focus groups and workshops 
where mothers and others involved in the singing sessions 
were able to share their experience of the sessions. This 
body of work allowed the refinement of the sessions for 
the intervention to be more suitable for the population.
A previous RCT was designed and delivered by two of 
this study’s coauthors (DF and RP), along with Breathe.36 
The RCT analysed the clinical efficacy of the intervention 
on a smaller scale and explored the experiences of partic-
ipants receiving and delivering the intervention, which 




The main statistical analyses will be carried out by the 
trial statistician who will be blind to the group randomis-
ation until the main analyses are complete. The analyses 
outlined in this strategy will be primarily based on inten-
tion to treat. A per- protocol analysis will also be conducted 
in which the primary outcome will also be compared 
between groups, removing data of participants who:
1. Do not complete their intervention as defined above. 
2. Miss over 50% of the singing or control sessions. 3. Are 
later found to have an exclusion criterion that was missed.
The first stage of analyses will be a descriptive model of 
the data to assess their completeness. Initially, a complete 
case analysis was performed under a missing at random 
assumption (MAR) where explanatory variables could 
predict the missing values in the respective outcome vari-
able. These models drop any participant who does not 
provide outcome data at the follow- up time point.
Mother- level baseline variables will be described both 
overall and by randomised groups. Patterns of missing 
data will be described, if any. predictors of missingness will 
be also assessed. The primary outcome will be analysed 
using linear mixed models to model the change in total 
score of EPDS at 6 weeks, 10 weeks, 20 weeks and 36 weeks 
postrandomisation. A three- level hierarchical model will 
be employed with all- time points included as repeated 
measures in the model (6 weeks, 10 weeks, 20 weeks and 
36 weeks postrandomisation) adjusting for baseline EPDS 
to improve power and take into account clustering of 
the observation at mother’s level. Associations between 
postrandomisation variables and missingness will be 
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dealt with by multiple imputation by chained equations, 
again under the MAR assumption. Departures from this 
assumption will be assessed with a sensitivity analysis. 
All baseline characteristics as well as the outcomes will 
be included in the multiple imputation (MI) models. 
Secondary outcomes (eg, PSS, HAM- D) will be assessed 
with a similar methodology for the primary outcomes, 
using generalised linear mixed models depending on the 
type of outcome (normal, binary and count). The ques-
tionnaires to be used have validated methods of scoring, 
and the scores will be analysed as described. All analyses 
will be conducted in STATA V.15.1.
Qualitative analyses
Data from the focus groups will be analysed using 
Thematic Analysis,39 to understand the lived experience 
of PND and how this relates to experiences in the singing 
group. Data from the individual/small- group interviews 
with sub- groups of women self- reporting particular risk 
factors for PND (traumatic birth, adverse childhood 
experiences, and social isolation/loneliness) will be anal-
ysed using Interpretative Phenomenological Analysis40 to 
focus in- depth on how singing intersects with the specific 
context of PND among women in these sub- groups.
ETHICS AND DISSEMINATION
Ethical approval has been granted by the London- West 
London and GTAC Research Ethics Committee, REC 
reference: 20/PR/0813.
Samples will be handled according to HTA regulations. 
All data will be handled in line with GDPR and other rele-
vant regulations.
Informed consent will be collected from all research 
participants and stakeholders involved in the study.
Findings will be published in peer- reviewed journals 
and disseminated at national and international meetings. 
Participants will be made aware of the results of the study 
through a newsletter.
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